Please Wait.....
Report
Israel Anti-Hypertensive Drugs Market, By Therapeutic Class (Diuretics, ACE inhibitors, Angiotensin Receptor Blockers (ARBs), Calcium Channel Blockers, Beta Adrenergic Blockers, Renin Inhibitors, Vasodilators, Others), By Type (Primary Hypertension, Secondary Hypertension), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-commerce Websites & Online Drug Stores), By Region, Competition Forecast & Opportunities, 2028F
Market Report I 2023-08-01 I 75 Pages I TechSci Research
The Israel Anti-Hypertensive Drugs Market is expected to experience impressive growth during the forecast period of 2024-2028. Major contributing factors include the increasing prevalence of hypertension due to kidney diseases, diabetes, obstructive sleep apnea, and other cardiovascular diseases. This has led to a significant rise in hypertension prevalence in recent years. Furthermore, certain drugs can induce hypertension in patients with other diseases or disorders, thus fostering growth in the Israel Anti-Hypertensive Drugs market. According to the World Health Organization in 2021, approximately 1.13 billion people worldwide have hypertension, with two-thirds residing in low- and middle-income countries.
Hypertension constitutes a preventable risk factor for atherosclerotic diseases and ischemic heart diseases. Characterized by elevated blood pressure in the arteries, many patients struggle to achieve optimal blood pressure control despite the availability of modern and effective antihypertensive drugs. To prevent heart stroke, most hypertensive patients require a combination of antihypertensive agents.
Furthermore, the rise in awareness concerning hypertension complications significantly fuels the Israel anti-hypertensive drugs market's growth. The aging population and sedentary lifestyles also contribute to market expansion. However, recent patent expirations are anticipated to impede market growth, while increased research into antihypertensive drugs offers promising opportunities.
The increasing prevalence of hypertension is a significant health concern across the country. Recent data indicates that around 25% of Israel's adult population is affected by hypertension, with prevalence increasing with age. Aging population demographics contribute to this rise, as the risk of hypertension increases with age. Additionally, unhealthy lifestyle habits like high salt and saturated fat consumption, sedentary behavior, and smoking are key factors driving hypertension prevalence. Obesity, a major hypertension risk factor, is also on the rise. In response, healthcare providers emphasize early detection, treatment, and lifestyle changes. Ongoing research into effective hypertension treatments is essential in curbing its prevalence and driving demand for anti-hypertensive drugs in Israel.
Advancements in drug development are pivotal. In April 2021, Radnor Biopharma developed a hormone-based hypertension treatment. Patent expirations and side effects associated with hypertension treatments, coupled with non-pharmacological therapy availability, may restrict market growth. For example, AbbVie's patent loss for the anti-hypertensive drug Bystolic (Nebivolol) in December 2021 limits its market. Conversely, advancements like hormone targeting treatments and generic equivalents, such as Dr. Reddy's Valsartan tablets, are driving market expansion.
Government initiatives and funding, along with increased awareness, boost market growth. Israel collaborates with the United Nations to improve older persons' lives, with initiatives promoting awareness and offering health camps for blood pressure checks. Public health campaigns, educational programs, and guidelines by Israel's Ministry of Health further emphasize blood pressure management, driving awareness and treatment efforts.
In conclusion, the Israel Anti-Hypertensive Drugs Market is poised for significant growth. Factors such as rising hypertension prevalence, advancements in drug development, government initiatives, and growing awareness of health risks contribute to this expansion. Continued efforts to educate the public and implement preventive measures will likely decrease hypertension prevalence, driving further market growth.
Market Segmentation
Israel Anti-Hypertensive Drugs Market can be segmented by therapeutic class, type, distribution channel, and region. By therapeutic class, the market can be segmented into Diuretics, ACE inhibitors, Angiotensin Receptor Blockers (ARBs), Calcium Channel Blockers, Beta Adrenergic Blockers, Renin Inhibitors, Vasodilators, Others. Based on type, the market can be segmented into Primary Hypertension and Secondary Hypertension. In terms of Distribution Channel, the market can be segmented into Retail Pharmacy, Hospital Pharmacy, E-commerce Websites & Online Drug Stores.
Market Players
Pfizer Pharmaceuticals Israel Ltd, MERCK SERONO LTD., AstraZeneca Israel Inc, Novartis Pharma Israel Ltd, Sanofi-Aventis Israel Ltd, Boehringer Ingelheim Israel Ltd., Bristol-Myers Squibb Israel Ltd., Takeda Israel Inc., Teva Israel Ltd., Servier Israel Inc. etc. are some of the leading companies operating in the Israel anti-hypertensive drugs market.
Report Scope:
In this report, Israel Anti-Hypertensive Drugs Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
- Israel Anti-Hypertensive Drugs Market, By Therapeutic Class
o Diuretics
o ACE inhibitors
o Angiotensin Receptor Blockers (ARBs)
o Calcium Channel Blockers
o Beta Adrenergic Blockers
o Renin Inhibitors
o Vasodilators
o Others
- Israel Anti-Hypertensive Drugs Market, By Type
o Primary Hypertension
o Secondary Hypertension
- Israel Anti-Hypertensive Drugs Market, By Distribution Channel
o Retail Pharmacy
o Hospital Pharmacy
o E-commerce Websites
o Online Drug Stores
- Israel Anti-Hypertensive Drugs Market, By Region:
o The Mediterranean Coastal Plain
o The Central Hills
o The Jordan Rift Valley
o The Negev Desert
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Israel Anti-Hypertensive Drugs Market
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Types
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Voice of Customer
5. Israel Anti-Hypertensive Drugs Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Therapeutic Class (Diuretics, ACE inhibitors, Angiotensin Receptor Blockers (ARBs), Calcium Channel Blockers, Beta Adrenergic Blockers, Renin Inhibitors, Vasodilators, Others)
5.2.2. By Type (Primary Hypertension, Secondary Hypertension)
5.2.3. By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-commerce Websites & Online Drug Stores)
5.2.4. By Region (The Mediterranean Coastal Plain, The Central Hills, The Jordan Rift Valley, The Negev Desert)
5.2.5. By Company (2022)
5.3. Market Map
6. The Mediterranean Coastal Plain Anti-Hypertensive Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Therapeutic Class
6.2.2. By Type
6.2.3. By Distribution Channel
7. The Central Hills Anti-Hypertensive Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Therapeutic Class
7.2.2. By Type
7.2.3. By Distribution Channel
8. The Jordan Rift Valley Anti-Hypertensive Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Therapeutic Class
8.2.2. By Type
8.2.3. By Distribution Channel
9. The Negev Desert Anti-Hypertensive Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Therapeutic Class
9.2.2. By Type
9.2.3. By Distribution Channel
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
11.1. Merger & Acquisition
11.2. Product Development
11.3. Recent Developments
12. Policy & Regulatory Landscape
13. Israel Economic Profile
14. Competitive Landscape
14.1. Business Overview
14.2. Company Snapshot
14.3. Products & Services
14.4. Financials (As Reported)
14.5. Recent Developments
14.5.1. Pfizer Pharmaceuticals Israel Ltd
14.5.2. MERCK SERONO LTD.
14.5.3. AstraZeneca Israel Inc
14.5.4. Novartis Pharma Israel Ltd
14.5.5. Sanofi-Aventis Israel Ltd
14.5.6. Boehringer Ingelheim Israel Ltd.
14.5.7. Bristol-Myers Squibb Israel Ltd.
14.5.8. Takeda Israel Inc.
14.5.9. Teva Israel Ltd.
14.5.10. Servier Israel Inc.
15. Strategic Recommendations
16. About Us & Disclaimer
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security